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Abstract 
Aims: Implantable cardioverter-defibrillator (ICD) treatment prevents sudden cardiac death in 
high-risk patients. This study examined geographical variation in ICD implantation rates in Den-
mark and potential causes of variation. 
Methods and Results: We obtained numbers of ICD implantations in the 5 Danish regions and 98 
municipalities during 2007-2013 from the Danish Pacemaker and ICD Registry. Standardized im-
plantation rates (SIRs) were computed as ICD implantations per 1,000,000 person-years, and 
age- and gender-standardized to the Danish population. We examined associations of the munic-
ipal SIR with mean age and Charlson Comorbidity Index score of ICD recipients, percentage of 
implantations with primary prophylactic indication, and distance from patient residency to ICD 
implanting centre. Based on 7,192 ICD implantations, the nationwide SIR was 186 (95% confi-
dence interval [CI]: 182-190), ranging from 170 (95% CI: 158-183) in the North Denmark Region 
to 206 (95% CI: 195-218) in the Region of Zealand. Municipalities with higher patient comorbidity 
scores, higher percentages of implantations with primary prophylactic indication, and shorter 
distances to ICD implanting centres, had higher SIRs (differences between SIRs of municipalities 
in highest and lowest quartiles = 22 [95% CI: 10-34], 45 [95% CI: 33-58], and 35 [95% CI: 24-47], 
respectively). Regional differences in SIRs decreased over time and had become insignificant 
during 2011-2013.  
Conclusion: ICD implantation rates in Denmark varied significantly between regions but variation 
decreased during 2007-2013. Geographical variation was associated with differences in patient 
comorbidity score, variation in use of primary prophylactic ICD treatment, and distance to ICD 
implanting centre.  
 
Keywords: Implantable cardioverter-defibrillator; implantation rate; variation; epidemiology; 
cross-sectional study 
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Introduction  
Implantable cardioverter-defibrillator (ICD) treatment reduces risk of sudden cardiac death, and 
international guidelines recommend ICD implantation for high-risk patients.1 Although evidence-
based, adherence to guidelines may vary in clinical practice, and ICD implantation rates vary con-
siderably internationally.1,2,3 This is partly explained by differences between national economies 
and health care systems.3,4 However, significant variation in ICD implantation rates has also been 
reported within nations,5,6,7,8 indicating that other factors contribute. Differences in implantation 
rates may reflect both over- and underuse and it is difficult to assess the optimal implantation 
rate. While >10% of patients receiving primary prophylactic ICDs did not meet guideline criteria 
in one study,5 this potential overuse alone did not explain the geographical variation observed.  
Other reports have suggested underuse among eligible patients in areas with low implan-
tation rates as a reason for geographical variation in implantation rates, rather than overuse in 
areas with high implantation rates.9 Of notice, areas with increases in ICD utilization have been 
reported to have larger improvements in heart failure survival.10 Pokorney et al. reported that 
fewer than 1 in 10 eligible patients received a primary prophylactic ICD within one year after 
myocardial infarction in the United States during 2007-2010.11 In a study of 2,093 cases of sud-
den cardiac arrest in the community during 2003-2012, only 13% of patients eligible for primary 
prophylactic ICD implantation prior to the event had actually received an ICD.12 These findings 
suggest that identification of factors impeding ICD implantation in eligible patients is a para-
mount issue in the prevention of sudden cardiac death. Regional variation in ICD implantation 
rates may reflect inequity in access to ICD implantation for eligible patients. However, few stud-
ies have identified potential determinants of regional variation in ICD implantation rates.9 
The aims of the present study were to 1) examine whether regional ICD implantation rates 
vary significantly in Denmark, 2) identify patient- and device-related factors associated with geo-
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graphical variation in ICD implantation rates, and 3) examine temporal trends in geographical 
variation in ICD implantation rates. 
 
Methods 
Study design and setting 
We conducted this nationwide cross-sectional study in Denmark using the cumulative population 
of 6.3 million inhabitants during 2007-2013. Health care in Denmark is tax-funded and free-of-
charge, guaranteeing all inhabitants unfettered access to general practitioners and hospitals.13 
Each Danish inhabitant has a unique civil registration number allowing for accurate and unam-
biguous linkage of national registries.13 Denmark is divided into 98 municipalities within 5 re-
gions: the Capital Region, the Region of Zealand, the North Denmark Region, the Central Den-
mark Region, and the Region of Southern Denmark. The average number of inhabitants per re-
gion is 1.2 million, ranging from 0.59 million in the North Denmark Region to 1.8 million in the 
Capital Region. The average number of inhabitants per municipality is 59,000, ranging from 
1,800 to 613,000. The Danish Civil Registration System contains current and previous addresses 
of residency for all Danish inhabitants and is updated daily.13  
In the regions of North Denmark, Central Denmark, and Southern Denmark all ICD implan-
tations are performed in Aalborg University Hospital, Aarhus University Hospital, and Odense 
University Hospital, respectively. In the Capital Region and the Region of Zealand, all ICD implan-
tations were performed in Gentofte Hospital and Rigshospitalet during the study period. More 
than 99% of all ICD implantations in Denmark were performed in these five regional ICD centres, 
and Denmark has a relatively low number of ICD implanting centres compared with other Euro-
pean nations (approximately 0.87 centres per million inhabitants).3 The geographical localization 
of the five regional ICD implanting centres is illustrated in Figure 1 and their municipal referral 
areas are listed in Table S1.  
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Data sources 
The Danish Pacemaker and ICD Registry (DPIR) contains information about all ICD implantations 
performed in Denmark. The registry includes information about the ICD recipient (date of birth, 
gender, underlying cardiac diagnosis) and the implantation (date, indication, ICD centre, device 
type [ICD or cardiac resynchronization therapy (CRT-D)]).  
The Danish National Patient Registry (DNPR) maintains records of all hospitalizations in 
Denmark.14 Upon hospital discharge, the treating physician records a primary diagnosis describ-
ing the main reason for diagnostic work-up and treatment, and up to several secondary diagno-
ses describing comorbid conditions.14 Diagnoses are coded according to the World Health Organ-
ization’s International Classification of Diseases, Eighth Revision (ICD-8) before 1993 and Tenth 
Revision (ICD-10) thereafter. Both primary and secondary hospital inpatient and outpatient dis-
charge diagnoses were included in our analyses.  
 
ICD patients 
Using the DPIR, we identified all first-time ICD recipients in Denmark during 2007-2013. We ex-
cluded immigrants because data on previous comorbidities could have been missing for hospital-
izations prior to ICD implantation. Residents of Greenland, an autonomous constituent country 
within the Kingdom of Denmark, were excluded because of the distinctive culture and remote 
geographical position of the island. Residents of the Faroe Islands, another autonomous country 
within the Kingdom of Denmark, are not registered in the Danish Civil Registration System and 
were not included in the study. 
Based on all discharge diagnoses registered in DNPR before or on the day of ICD implanta-
tion, we computed the comorbidity score according to the Charlson Comorbidity Index for each 
patient.15 The Charlson Comorbidity Index has been validated for use with DNPR hospital dis-
charge data15 and has proved an adequate tool for measuring the prognostic impact of comor-
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bidity in ICD patients.16 Each patient’s municipal address on the day of ICD implantation was ob-
tained from the Danish Civil Registration System.13 The distance from regional ICD implanting 
centre to each of the municipalities in the respective referral area was ascertained using the web 
mapping service Google Maps, © 2015 Google Inc. (Table S1).  
 
Statistical analysis 
We ascertained the number of first-time ICD implantations performed in each region and munic-
ipality of Denmark, overall and for the first and latter part of the study period, 2007-2010 and 
2011-2013, respectively. Implantation rates were computed as number of implantations per 
1,000,000 person-years, and standardized to the age- and gender-distribution of all Danish in-
habitants during 2007-2013. Implantation rates were computed overall, and for men and wom-
en, respectively. The approximate bootstrap method was used to compute 95% confidence in-
tervals (CIs) of the standardized implantation rates (SIRs). We computed implantation rate ratios 
(IRRs), comparing the lowest and highest regional SIRs, and comparing regional SIRs with the 
nationwide SIR, overall and for the periods 2007-2010 and 2011-2013, respectively.  
We categorized ICD implantations according to gender, age (<60 years, 60-69 years, or ≥70 
years), and Charlson Comorbidity Index score (≤1, 2, 3, or ≥4 points) of ICD recipients, as well as 
device type (ICD or CRT-D) and indication (primary or secondary prophylaxis), overall and accord-
ing to region and municipality. The mean age and comorbidity score of ICD recipients were com-
puted overall and for each region and municipality.  
To examine its association with potential determinants of geographical variation, the SIR 
was plotted against 1) the municipal mean age of ICD recipients, 2) the municipal mean comor-
bidity score of ICD recipients, 3) the municipal percentage of implantations performed as prima-
ry prophylaxis, and 4) the distance from patient residency to ICD implanting centre. As a meas-
ure of the strength of association, the Pearson correlation coefficient, r, was computed. Fur-
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thermore, SIRs were compared for municipalities in the lowest versus highest quartile according 
to 1) the municipal mean age of ICD recipients, 2) the municipal mean comorbidity score of ICD 
recipients, 3) the municipal percentage of implantations performed as primary prophylaxis, and 
4) the distance from patient residency to ICD implanting centre. Statistical analyses were per-
formed using SAS version 9.4 (SAS Institute Inc., Cary, NC, USA). The study was approved by the 
Danish Data Protection Agency (record no. 1-16-02-267-12) and by the steering committee of 
the DPIR. According to Danish legislation, approval from an ethics committee was not needed for 
this registry-based study. 
 
Results 
Implantations overall 
After exclusion of 46 patients (23 with unknown address, 14 with no registered identification of 
the implantation site, and 9 residents of Greenland), we included 7,192 first-time ICD recipients. 
Men constituted 80% of the study population (Table 1). The mean age of ICD recipients was 63 
(median = 66 [IQR: 57-72]) years and the mean Charlson Comorbidity Index score was 2.3 (medi-
an = 2.0 [IQR: 1.0-3.0]) points (Table 1). The indication for implantation was primary prophylactic 
in 50% of cases and 26% of devices were CRT-Ds (Table 1). The SIR was 186 (95% CI: 182-190) per 
million person-years, 300 (95% CI: 292-308) for men (Table S3) and 74 (95% CI: 70-78) for wom-
en (Table S4).  
 
Regional variation 
SIRs were higher in the Capital Region and the Region of Zealand than in the Regions of North 
Denmark, Central Denmark, and Southern Denmark (Figure 1A and Table 2), particularly for men 
(Table S3). The ratio comparing the lowest regional SIR with the highest was 1.21, 1.27 for men 
and 1.14 for women. Ratios comparing regional SIRs with the nationwide SIR ranged from 0.91 
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to 1.11 (Table 2), from 0.88 to 1.12 for men (Table S3) and from 0.96 to 1.10 for women (Table 
S4). Men constituted less than 80% of ICD recipients in the regions of North Denmark and 
Southern Denmark, and more than 80% of ICD recipients in the regions of Central Denmark, Zea-
land and the Capital (Table 1). ICD recipients in the Region of Zealand, which had the highest SIR, 
were older with higher comorbidity scores than ICD recipients in Denmark overall, while ICD 
recipients in the regions of North Denmark and Southern Denmark had lower mean comorbidity 
scores than ICD recipients in Denmark overall (Table 1). The proportion of implantations with 
primary prophylactic indication ranged from 39% in the North Denmark Region to 60% in the 
Region of Zealand (Table 1). The proportion of CRT-Ds ranged from approximately 23% in the 
Region of Southern Denmark and the Capital Region to 32% in the Central Denmark Region (Ta-
ble 1).  
 
Factors associated with implantation 
Figure 1 illustrates municipal SIRs in Denmark. Overall, municipal SIRs did not correlate, or corre-
lated poorly, with mean age and comorbidity score of ICD recipients, percentage of implanta-
tions with primary prophylactic indication, and distance from patient residency to ICD implanting 
centre (Figure 2). However, the strength of correlations varied between regions (Table 3). In par-
ticular, municipal SIRs in the region of North Denmark correlated inversely with distance from 
patient residency to ICD implanting centre, while this correlation was weaker in other regions of 
Denmark (Table 3). In the Region of Central Denmark, we found that municipal SIRs correlated 
moderately with the mean comorbidity score of ICD recipients (Table 3).  
We found significant differences between the SIRs when municipalities were sorted into 
lowest and highest quartiles according to mean age of ICD recipients, mean comorbidity score of 
ICD recipients, percentage of implantations with primary prophylactic indication, and distance 
from patient residency to ICD implanting centre, respectively (Table 4). 
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Temporal changes 
The nationwide SIR increased by approximately 20% from 2007-2010 to 2011-2013 (Table 2), by 
22% for men (Table S3) and by 13% for women (Table S4). The proportion of male recipients, 
mean age and CCI score showed slightly increasing trends over time (Table 1). The proportion of 
implantations performed as primary prophylaxis increased from 47% during 2007-2010 to ap-
proximately 54% during 2011-2013 (Table 1), while the proportion of devices that were CRT-Ds 
increased from approximately 24% to 28%. The SIR increased significantly in almost all regions 
(Table 2, Figures 1B and 1C). The largest relative increases occurred in the Central Denmark Re-
gion (29%), the Southern Denmark Region (29%), and the North Denmark Region (18%), while 
relative increases were smaller in the Capital Region (13%) and the Region of Zealand (10%). 
Accordingly, the span in ratios comparing regional SIRs with the nationwide SIR decreased over 
time (Table 2), and while SIRs in the Capital Region and the Region of Zealand were significantly 
higher than SIRs in other regions during 2007-2010, SIRs did not differ significantly between re-
gions during 2011-2013 (Table 2). The ratio comparing the lowest regional SIR with the highest 
decreased by 9% (from 1.28 during 2007-2010 to 1.16 during 2011-2013), by 4% for men (from 
1.29 to 1.24) and by 17% for women (from 1.55 to 1.28).  
The observed differences in SIRs between upper and lower quartiles of municipalities also 
decreased over time (Table 4). While statistically significant when sorted by mean comorbidity 
score of ICD recipients, percentage of implantations with primary prophylactic indication, and 
distance from patient residency to ICD implanting centre during 2007-2010, only SIRs of upper 
and lower quartile municipalities sorted by distance from patient residency to ICD implanting 
centre differed significantly during 2011-2013 (Table 4).  
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Discussion 
Main findings 
This nationwide study, in a country with a tax-paid health care system offering universal cover-
age to all inhabitants, showed significant geographical variation in ICD implantation rates in 
Denmark during 2007-2013. Implantation rates were four times higher among men than among 
women, but gender differences were not larger in regions with lower implantation rates. We 
observed moderate to strong linear correlations of municipal implantation rates with mean 
comorbidity score of ICD recipients and distance from patient residency to ICD implanting centre 
in some regions. The regional differences in ICD implantation rates were significant during 2007-
2010, but decreased over time and were not significant anymore during 2011-2013.  
Lower comorbidity score of ICD recipients, lower percentage of implantations with primary 
prophylactic indication, and longer distance from patient residency to ICD implanting centre 
were significantly associated with lower municipal implantation rates during 2007-2010, while 
only distance from patient residency to ICD implanting centre remained significantly associated 
with implantation rate during 2011-2013. 
 
Comparison with other countries 
Regional variation in ICD implantation rates has been reported in other European countries and 
in the United States during the same study period as ours.5-7,9 Ratios comparing regional rates of 
primary prophylactic ICD implantation with the national average in the United States during 
2006-2007 ranged from 0.39 to 1.77.5 In comparison, ratios in our study ranged from 0.91 to 
1.16 during 2007-2010 when regional differences were most significant. In a systematic review 
of 58 European cardiac implantable electronic implant studies, Valzania et al. demonstrated that 
the ratio between the regions with the highest and lowest ICD implantation rates within the 
same country ranged from 1.7 to 44.0.9 Our ratio of 1.21 demonstrated that regional variation is 
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less pronounced in Denmark than reported in any other country. The most likely reason is that 
Denmark is a small country with socioeconomic homogeneity and equal access to the public 
health care system independent of individual socioeconomic status. Regional differences in gross 
domestic products and health care expenditures per capita, suggested to account for significant 
differences in ICD implantation rates in other parts of Europe,9 are less pronounced in Den-
mark.14 Still, significant differences in implantation rates were observed between Western and 
Eastern Denmark, supporting previous reports suggesting that factors other than gross domestic 
products and health care expenditures per capita are determinants of ICD use.3,9  
 
Variation in indication for ICD implantation  
In agreement with our findings, a French study previously reported that patients in regions with 
higher rates of ICD implantation were more likely to undergo implantation for primary preven-
tion.7 The underlying explanation for the geographical differences in proportions of primary 
prophylactic ICD implantation probably is multifactorial. Differences in both patient referral and 
propensity to accept ICD treatment may influence implantation rates and barriers to referral 
include both physician- and patient-related factors. For instance, women have been reported to 
have lower likeliness of referral for and receiving primary prophylactic ICD implantation,11,17 and 
to decline implantation more often than men.18 The difference in SIRs for men and women in our 
study seem to support a lower likeliness of ICD implantation in women than in men in general, 
but the gender differences in ICD implantation rates were not more pronounced in regions with 
lower overall ICD implantation rates. Thus, lower implantation rates among women are unlikely 
to explain the regional variation observed. However, regional differences in ICD implantation 
rates decreased more for women than for men during the study period, and increased aware-
ness of indications for ICD implantation in women in certain regions possibly contributed to the 
overall decrease in regional variation. 
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Another possible explanation for the differences observed, is varying awareness of the in-
dications for primary prophylactic ICD implantation among health care professionals. Since 2006, 
Danish guidelines have recommended ICD implantation as primary prophylaxis for patients with 
ischaemic heart disease and left ventricular ejection fraction ≤35% in New York Heart Associa-
tion class II-III despite optimal medical treatment. During the study period, primary prophylactic 
ICD implantation was not recommended for patients with heart failure of non-ischaemic origin. 
The results of the present study may indicate that these guidelines were implemented faster in 
the Eastern part of Denmark than in the Western part, resulting in higher implantation rates in 
the Eastern part. This interpretation supports that education and more widespread knowledge 
about ICD indications reduce geographical differences in implantation rates. The decrease in 
regional differences of ICD implantation rates over time may reflect increasing implementation 
of guidelines for primary prophylactic implantation in Denmark and decreasing inequity in access 
to ICD treatment for eligible patients.  
 
Factors associated with ICD implantation 
In accordance with the previous finding that patients receiving primary prophylactic ICDs have 
higher Charlson Comorbidity Index scores than patients receiving secondary prophylactic ICDs,19 
we found higher comorbidity scores of ICD recipients in regions with more frequent use of pri-
mary prophylactic ICD treatment. Comorbidity may be associated with a significant risk of non-
arrhythmic death and the disadvantages of ICD treatment may attenuate the benefits in some 
patients with severe comorbidity. The risk-benefit analysis of ICD implantation in patients with 
comorbidity often is complicated, and the association between the SIR and the mean CCI score 
of ICD recipients observed in our study may result from regional differences in the individual 
judgment of primary prophylactic ICD indication with different levels of comorbidity. 
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Even though Denmark is a small country with relatively short distances, we observed that 
the SIR decreased with increasing distance from patient home to ICD implanting centre. Several 
factors may explain this association. Patients living far from an ICD implanting centre may be less 
likely to be referred for ICD implantation or more likely to decline implantation. As ICD implanta-
tion is without any direct financial costs for the recipient and all expenses are reimbursed to the 
implanting centre, reluctance to receive or offer ICD implantation for financial reasons is unlikely 
to occur in Denmark. Implantation is usually performed ≥90 days after myocardial infarction and 
regional differences in cardiac rehabilitation programs and patient participation may therefore 
play an important role. Patients living far from the local hospital offering cardiac rehabilitation 
more often refuse to participate in cardiac rehabilitation programs or drop out from such pro-
grams.20 Consequently, primary prophylactic ICD treatment may be offered less frequently to 
eligible patients living far from the local hospital. This may partly explain the association be-
tween distance to ICD implanting centre and the SIR, as most patients living far from the local 
hospital also live far from the regional ICD implanting centre. Of notice, longer distance from 
patient residency to ICD implanting centre remained significantly associated with lower implan-
tation rate during 2011-2013, thereby uncovering a possible potential for further improvement 
of the prevention of sudden cardiac death.  
 
Strengths and Limitations 
The strengths of this study lie in its nationwide design within the setting of a tax-paid health care 
system offering universal coverage to all inhabitants and its use of national registries with pro-
spectively recorded data of high quality. Due to longitudinal data and a large sample size, we 
were able to observe temporal changes in ICD implantation rates and identify several factors 
associated with implantation, thereby uncovering potential causes for inequity in access to ICD 
treatment.  
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Our study is limited by its observational study design precluding causal inference, and we 
could not show a consistent reason for variation in ICD implantation rates, or that correcting it 
increased implantation rates. Another limitation is that some municipal SIRs were based on small 
numbers of implantations, leading to imprecise estimates requiring cautious interpretation. We 
controlled for confounding by age and gender through standardization of implantation rates, but 
residual confounding cannot be excluded. Although a previous study conducted in England re-
ported no associations between ICD implantation rates and multiple socioeconomic factors,8  
including income, employment, and education, socioeconomic differences that were not cor-
rected for in the statistical analyses may have affected our results. Some of the variation ob-
served in our study may be attributable to epidemiological differences, for instance regional 
differences in the incidence of myocardial infarction. However, a visual comparison of municipal 
SIRs in our study with municipal incidences of myocardial infarction in Denmark during the study 
period (not shown) did not suggest a remarkable association, nor did previous studies demon-
strate that ICD implantation rates were associated with incidence of myocardial infarction9 or 
standardized mortality rates for acute myocardial infarction.8,9  
 
Conclusions 
This nationwide study showed significant regional variation in ICD implantation rates in Denmark 
during 2007-2013, but regional differences decreased over time and became statistically insignif-
icant during 2011-2013. Although significant gender differences in ICD implantation rates were 
found, gender differences in ICD implantation rates did not explain the regional variation ob-
served. Lower mean comorbidity score of ICD recipients, lower percentage of implantations with 
primary prophylactic indication, and longer distance from patient residency to ICD implanting 
centre were associated with lower implantation rates during 2007-2010, while only distance to 
ICD implanting centre remained significantly associated with the SIR throughout our study peri-
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od. Our findings indicate that regional inequity in access to ICD treatment in Denmark has de-
creased over time, but that distance to ICD implanting centre may still be an obstacle to ICD 
treatment in eligible patients. Future studies are needed to further elucidate and address the 
underlying causes for variation in ICD implantation rates. 
 
Supplementary Data 
Registry codes used in the current study and distances from municipalities to implantation cen-
tres are provided in the supplementary online material.  
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Figure Legend 
 
Figure 1. Municipal age- and gender-standardized implantation rates of first-time implantable 
cardioverter-defibrillators in Denmark during A) 2007-2013, B) 2007-2010, and C) 2011-2013. 
Regional borders and implantation centres are black. C = Central Denmark Region; CA = Capital 
Region; N = North Denmark Region; S = Region of Southern Denmark; Z = Region of Zealand.  
 
Figure 2. Linear correlations between municipal standardized implantation rates of cardioverter-
defibrillators during 2007-2013 in Denmark and A) mean age of ICD recipients, B) mean Charlson 
Comorbidity Index score of ICD recipients, C) percentage of implantations with primary prophy-
lactic indication, and D) distance from patient residency to ICD implanting centre. 
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Table 1. Characteristics of ICD recipients and implantations in Denmark during 2007-2013. 
Characteristics,  
n (%) or mean (95% CI) 
2007-2013 2007-2010 2011-2013 
All regions    
Implantations 7,192 (100.0) 3,680 (100.0) 3,512 (100.0) 
Male 5,752 (79.9) 2,919 (79.3) 2,833 (80.7) 
Age  63.1 (62.8-63.4) 62.8 (62.4-63.2) 63.3 (62.9-63.8) 
CCI score 2.3 (2.2-2.3) 2.2 (2.2-2.3) 2.3 (2.2-2.4) 
CRT-D 1,866 (25.9) 887 (24.1) 979 (27.9) 
Primary prophylaxis 3,622 (50.4) 1,739 (47.3) 1,883 (53.6) 
North Denmark Region    
Implantations 729 (100.0) 377 (100.0) 352 (100.0) 
Male 564 (77.4) 285 (75.6) 279 (79.3) 
Age  62.4 (61.4-63.5) 62.5 (61.1-63.9) 62.3 (60.8-63.9) 
CCI score 2.0 (1.9-2.1) 2.1 (2.0-2.3) 1.8 (1.6-2.0) 
CRT-D 192 (26.3) 104 (27.6) 88 (25.0) 
Primary prophylaxis 283 (39.0) 139 (37.0) 144 (41.3) 
Central Denmark Region    
Implantations 1,512 (100.0) 740 (100.0) 772 (100.0) 
Male 1,214 (80.3) 604 (81.6) 610 (79.0) 
Age  63.1 (62.5-63.8) 62.6 (61.7-63.6) 63.6 (62.6-64.5) 
CCI score 2.4 (2.3-2.5) 2.3 (2.2-2.4) 2.4 (2.3-2.5) 
CRT-D 490 (32.4) 236 (31.9) 254 (32.9) 
Primary prophylaxis 764 (50.4) 347 (46.8) 417 (53.8) 
Region of Southern 
Denmark 
   
Implantations 1,528 (100.0) 754 (100.0) 774 (100.0) 
Male 1,207 (79.0) 593 (78.6) 614 (79.3) 
Age  62.3 (61.6-62.9) 62.0 (61.1-62.9) 62.6 (61.7-63.5) 
CCI score 2.0 (2.0-2.1) 2.0 (1.9-2.2) 2.0 (1.9-2.2) 
CRT-D 346 (22.6) 120 (15.9) 226 (29.2) 
Primary prophylaxis 622 (40.7) 283 (37.5) 339 (43.8) 
Capital Region    
Implantations 2,128 (100.0) 1,121 (100) 1,007 (100.0) 
Male 1,722 (80.9) 904 (80.6) 818 (81.2) 
Age  63.2 (62.6-63.7) 63.1 (62.3-63.9) 63.2 (62.4-64.0) 
CCI score 2.4 (2.3-2.4) 2.3 (2.2-2.4) 2.5 (2.3-2.6) 
CRT-D 489 (23.0) 255 (22.7) 234 (23.2) 
Primary prophylaxis 1,180 (55.5) 601 (53.6) 579 (57.5) 
Region of Zealand    
Implantations 1,295 (100.0) 688 (100.0) 607 (100.0) 
Male 1,045 (80.7) 533 (77.5) 512 (84.3) 
Age  64.2 (63.5-64.8) 63.6 (62.7-64.6) 64.8 (63.9-65.7) 
CCI score 2.5 (2.4-2.6) 2.4 (2.3-2.6) 2.6 (2.4-2.7) 
CRT-D 349 (26.9) 172 (25.0) 177 (29.2) 
Primary prophylaxis 773 (59.7) 369 (53.6) 404 (66.6) 
CI = confidence interval; CCI = Charlson Comorbidity Index; CRT-D = cardiac resynchronization 
therapy defibrillator. 
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Table 2. Implantation rates of cardioverter-defibrillators in Denmark during 2007-2013.   
Region 2007-2013 2007-2010 2011-2013 2007-2010 versus 
2011-2013 
 IR† (95% CI) SIR† (95% 
CI) 
IRR IR† (95% CI) SIR† (95% 
CI) 
IRR IR† (95% CI) SIR† (95% 
CI) 
IRR SIR 
difference 
(95% CI) 
p‡ 
All 186 (182-
190) 
186 (182-
190) 
ref 168 (162-
173) 
171 (166-
177) 
ref 210 (203-
217) 
205 (198-
211) 
ref 34 (25-42) <0.0001 
North 180 (167-
193) 
170 (158-
183) 
0.91 162 (146-
179) 
158 (142-
173) 
0.92 202 (181-
223) 
187 (168-
207) 
0.91 30 (4-55) 0.02 
Central 173 (164-
181) 
178 (169-
186) 
0.96 149 (139-
160) 
157 (146-
168) 
0.92 203 (190-
218) 
203 (189-
218) 
0.99 46 (28-64) <0.0001 
Southern 182 (174-
192) 
175 (166-
184) 
0.94 158 (147-
169) 
155 (144-
166) 
0.91 215 (200-
230) 
200 (186-
214) 
0.98 46 (28-64) <0.0001 
Capital 181 (173-
189) 
198 (189-
206) 
1.06 169 (160-
179) 
187 (176-
198) 
1.09 196 (184-
208) 
211 (198-
224) 
1.03 23 (6-40) 0.007 
Zealand 226 (214-
239) 
206 (195-
218) 
1.11 210 (194-
226) 
198 (184-
213) 
1.16 248 (228-
268) 
217 (200-
235) 
1.06 19 (-4-42) 0.11 
† Implantations per million person-years.  
‡ P-value for the difference between SIRs of 2007-2010 and 2011-2013. 
CI = confidence interval; IR = implantation rate; IRR = standardized implantation rate ratio; ref = reference; SIR = age- and gender-standardized 
implantation rate.  
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Table 3. Linear correlations between the standardized implantation rate and mean age of ICD 
recipients, mean Charlson Comorbidity Index score of ICD recipients, percentage of 
implantations with primary prophylactic indication, and distance from patient residency to ICD 
implanting centre in Denmark during 2007-2013. 
Region Pearson correlation coefficient, r† 
 Mean age  Mean CCI score  Primary 
prophylactic 
indication 
Distance 
Overall -0.008 0.35 0.38 -0.29 
North Denmark -0.46 -0.03 0.28 -0.73 
Central Denmark 0.11 0.63 0.41 -0.46 
Southern 
Denmark 
-0.08 0.18 0.37 -0.29 
Capital 0.13 0.12 -0.32 -0.22 
Zealand 0.10 -0.22 0.41 -0.20 
† A value of 1 indicates total positive linear correlation, a value of -1 indicates total inverse 
linear correlation, while a value of 0 indicates no linear correlation. 
CCI = Charlson Comorbidity Index; ICD = implantable cardioverter-defibrillator. 
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Table 4. Differences between standardized implantation rates of municipalities in the lowest versus highest quartile 
according to mean age and Charlson Comorbidity Index score of ICD recipients, percentage of implantations with primary 
prophylactic indication, and distance from patient residency to ICD implanting centre. 
 2007-2013 2007-2010 2011-2013 
 SIRL SIRU Difference 
(95% CI) 
p SIRL SIRU Difference 
(95% CI) 
p SIRL SIRU Difference 
(95% CI) 
p 
Mean age 181 194 13 (1-25) 0.04 157 173 16 (-1-34) 0.06 201 192 -9 (-28-10) 0.34 
Mean CCI 
score 
179 201 22 (10-34) 0.0003 142 178 36 (20-52) 0.0000 200 206 6 (-12-25) 0.51 
Primary 
prophylaxis 
percentage 
158 203 45 (33-58) 0.0000 141 189 48 (32-63) 0.0000 197 207 11 (-10-
32) 
0.32 
Distance to 
ICD centre 
206 171 -35 (-47--
24) 
0.0000 197 157 -40 (-54--
25) 
0.0000 219 188 -31 (-49--
13) 
0.0008 
CCI = Charlson Comorbidity Index; CI = confidence interval; ICD = implantable cardioverter defibrillator; SIRL = standardized 
implantation rate of municipalities in the lowest quartile; SIRU = standardized implantation rate of municipalities in the 
highest quartile. 
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